Clinical Trials Browser

Adenocarcinoma of Lung, Lung Neoplasms

NCT04396457 2023-03-23

Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

Phase 2 Unknown

50 enrolled

Thoracic

Lung Neoplasms

NCT03402048 2020-11-04

EPIC

Phase 3 Unknown

567 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT04592666 2020-10-19

APPEAL

Phase 2 Unknown

226 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03706703 2018-10-17

Rh-Endostatin (Endostar®) Continuous Intravenous Infusion

Phase 2 Unknown

50 enrolled

Thoracic

Lung Neoplasms

NCT03201146 2017-11-17

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Phase 1/2 Unknown

48 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02669719 2016-02-01

Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC

Phase 2 Unknown

70 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02518802 2015-08-10

Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma

Phase 3 Unknown

220 enrolled

Thoracic

Lung Neoplasms

NCT00989690 2013-08-12

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Phase 3 Unknown

275 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

ECTOP-1004

Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

EPIC

APPEAL

Rh-Endostatin (Endostar®) Continuous Intravenous Infusion

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC

Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer